Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Omnicell, Inc. (OMCL)

42.80 +1.38 (+3.33%)
At close: May 1 at 4:00:00 PM EDT
42.79 -0.01 (-0.02%)
After hours: May 1 at 5:29:27 PM EDT
Trade OMCL on Coinbase
Chart Range Bar
Loading chart for OMCL
  • Previous Close 41.42
  • Open 41.72
  • Bid 30.75 x 100
  • Ask 54.74 x 200
  • Day's Range 41.23 - 43.07
  • 52 Week Range 22.66 - 55.00
  • Volume 616,909
  • Avg. Volume 707,177
  • Market Cap (intraday) 1.946B
  • Beta (5Y Monthly) 0.86
  • PE Ratio (TTM) 97.27
  • EPS (TTM) 0.44
  • Earnings Date Apr 28, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 61.29

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

www.omnicell.com

3,580

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview: OMCL

Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OMCL
5.52%
S&P 500 (^GSPC)
5.62%

1-Year Return

OMCL
36.39%
S&P 500 (^GSPC)
29.01%

3-Year Return

OMCL
30.37%
S&P 500 (^GSPC)
73.47%

5-Year Return

OMCL
70.49%
S&P 500 (^GSPC)
72.92%

Earnings Trends: OMCL

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 309.88M
Earnings 25.04M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
100M
200M
300M

Analyst Insights: OMCL

View More

Analyst Price Targets

55.00
61.29 Average
42.80 Current
70.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/29/2026
Analyst Keybanc
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 60 -> 70

Statistics: OMCL

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    1.95B

  • Enterprise Value

    1.90B

  • Trailing P/E

    97.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.61

  • Price/Book (mrq)

    1.55

  • Enterprise Value/Revenue

    1.55

  • Enterprise Value/EBITDA

    15.97

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.67%

  • Return on Assets (ttm)

    1.21%

  • Return on Equity (ttm)

    1.63%

  • Revenue (ttm)

    1.23B

  • Net Income Avi to Common (ttm)

    20.43M

  • Diluted EPS (ttm)

    0.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    239.22M

  • Total Debt/Equity (mrq)

    15.16%

  • Levered Free Cash Flow (ttm)

    123.97M

Compare To: OMCL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: OMCL

Fair Value

42.80 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: OMCL

View More
  • Raising target price to $48.00

    OMNICELL INC has an Investment Rating of HOLD; a target price of $48.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
  • Raising target price to $39.00

    OMNICELL INC has an Investment Rating of HOLD; a target price of $39.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $38.00

    OMNICELL INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $33.00

    OMNICELL INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: